Perspective Therapeutics, Inc. (CATX) Presents at UBS Global Healthcare Conference 2025 Transcript

Xiaochuan Dai
UBS Investment Bank, Research Division

That’s great. Yes. Today is a little bit colder. Interesting, before we start diving into the Q&A, I just want to have a quick kind of logistic check. Anybody who wants to ask a question to management team, please feel free to scan the QR code on the screen here. And then after that, you can type in your questions, and they will show up on my iPad, and I’ll ask the question to the management team. So feel free to let me know if you have any questions on that.

All right. With that out of the way, Joel, Annie, great to have you again. So to start things off, just tell us a little bit more about Perspective Therapeutics. What’s your focus right now? And what are some of the key sort of like clinical programs you guys have right now?

Joel Sendek
Chief Financial Officer

Sure. So Perspective is a targeted radiopharmaceutical company, and we have a full slate of clinical programs, a full pipeline and a